R. Aneja

Publications243
h-index37
Citations4,115
Highly Influential Citations127
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • I. Ellis
  • 1,158 Publications • 62,186 Citations
  • E. Rakha
  • 382 Publications • 15,050 Citations
  • P. Rida
  • 79 Publications • 1,040 Citations
  • H. Joshi
  • 122 Publications • 5,373 Citations
  • Publications
  • Influence
Drugs that target dynamic microtubules: A new molecular perspective
Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle apparatus. As such, there is a wide variety… Expand
  • 296
  • 8
  • PDF
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
Human breast tumors harbor supernumerary centrosomes in almost 80% of tumor cells. Although amplified centrosomes compromise cell viability via multipolar spindles resulting in death-inducing… Expand
  • 53
  • 8
  • PDF
Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
Noscapine, a microtubule-interfering agent, has been shown to arrest mitosis, to induce apoptosis, and to have potent antitumor activity. We report herein that two brominated derivatives of… Expand
  • 131
  • 6
  • PDF
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.
A significant impediment to the success of cancer chemotherapy is multidrug resistance (MDR). A typical form of MDR is attributable to the overexpression of membrane transport proteins, such as… Expand
  • 94
  • 6
  • PDF
Drugs that Target Dynamic Microtubules: A New Molecular Perspective
  • 70
  • 6
Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer.
OBJECTIVES Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer, and there is no approved targeted therapy. We studied the expression of programmed cell death protein 1… Expand
  • 58
  • 6
Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy
Nearly a century ago, cell biologists postulated that the chromosomal aberrations blighting cancer cells might be caused by a mysterious organelle—the centrosome—that had only just been discovered.… Expand
  • 70
  • 5
  • PDF
Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
Tumor-infiltrating lymphocytes (TILs) provide prognostic value in invasive breast cancer and guidelines for their assessment have been published. This study aims to evaluate: (a) methods of TILs… Expand
  • 30
  • 5
Ginger Phytochemicals Exhibit Synergy to Inhibit Prostate Cancer Cell Proliferation
Dietary phytochemicals offer nontoxic therapeutic management as well as chemopreventive intervention for slow-growing prostate cancers. However, the limited success of several single-agent clinical… Expand
  • 65
  • 3
  • PDF
Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012.
EM012, a semisynthetic phthalideisoquinoline alkaloid, has been recently found to target microtubules and possess anti-cancer activity. In this study, we evaluated the effects of EM012 in combination… Expand
  • 29
  • 3
...
1
2
3
4
5
...